Intercept launches stock offerings totaling $212M; shares down 2% after hours

|About: Intercept Pharmaceuticals (ICPT)|By:, SA News Editor

Intercept Pharmaceuticals (NASDAQ:ICPT) commences a $120M public offering of common stock and a concurrent direct $92M offering of stock to current  investors including top shareholder Genextra S.p.A.

Prices, volumes and terms have yet to be announced. Net proceeds will fund working capital and general corporate purposes.

Shares are off 2% after hours on modest volume.

Subscribe for full text news in your inbox